國立虎尾科技大學 |

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry./
Author:	Adamu, Stephen A.
Description:	1 online resource (198 pages)
Notes:	Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.
Contained By:	Dissertation Abstracts International79-04B(E).
Subject:	Pharmaceutical sciences. -
Online resource:	click for full text (PQDT)
ISBN:	9780355548822

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
Adamu, Stephen A.

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry. - 1 online resource (198 pages)

Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.

Thesis (Ed.D.)

Includes bibliographical references

Many studies have examined the association between corporate social responsibility (CSR) and corporate financial performance, but scholars argue that the exact relationship between CSR and corporate financial performance remains unclear. This quantitative study examines the impact of CSR on corporate financial performance in the pharmaceutical industry. The study addresses the research question: What is the financial performance in the pharmaceutical industry among companies that have embraced CSR? The alternative hypothesis predicted positive correlations between financial performance and CSR. The related null hypotheses predicted that there would be no correlations between any of 8 dimensions of CSR and corporate financial performance. Archival data from 18 leading global pharmaceutical companies ranked by Access to Medicine Index were used to answer the research question.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9780355548822Subjects--Topical Terms:

1180569
Pharmaceutical sciences.
Index Terms--Genre/Form:

554714
Electronic books.

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
LDR:03764ntm a2200373Ki 4500 001 910118
005 20180511093035.5
006 m o u
007 cr mn||||a|a||
008 190606s2017 xx obm 000 0 eng d
020 $a 9780355548822
035 $a (MiAaPQ)AAI10689996
035 $a (MiAaPQ)pepperdinegsep:10982
035 $a AAI10689996
040 $a MiAaPQ $b eng $c MiAaPQ
099 $a TUL $f hyy $c available through World Wide Web
100 1 $a Adamu, Stephen A. $3 1181205
245 1 0 $a Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
264 0 $c 2017
300 $a 1 online resource (198 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.
500 $a Adviser: James Rocco DellaNeve.
502 $a Thesis (Ed.D.) $c Pepperdine University $d 2017.
504 $a Includes bibliographical references
520 $a Many studies have examined the association between corporate social responsibility (CSR) and corporate financial performance, but scholars argue that the exact relationship between CSR and corporate financial performance remains unclear. This quantitative study examines the impact of CSR on corporate financial performance in the pharmaceutical industry. The study addresses the research question: What is the financial performance in the pharmaceutical industry among companies that have embraced CSR? The alternative hypothesis predicted positive correlations between financial performance and CSR. The related null hypotheses predicted that there would be no correlations between any of 8 dimensions of CSR and corporate financial performance. Archival data from 18 leading global pharmaceutical companies ranked by Access to Medicine Index were used to answer the research question.
520 $a In 4 of the 8 hypotheses tested, the results show partial support for a positive effect of CSR on corporate financial performance in the pharmaceutical industry based on significant correlations in 2014. Specifically, significant 2014 relationships with corporate financial performance were observed for CSR general access to medicine management, CSR capacity advancement in product development and distribution, CSR product donations and philanthropic activities, and overall CSR. However, no significant 2014 relationships with corporate financial performance were observed for CSR public policy and market influence, CSR research and development, CSR pricing, manufacturing, and distribution, and CSR patents and licensing. In the 8 hypotheses tested, the findings in 2012 did not show any effect of CSR on corporate financial performance in the pharmaceutical industry. The results of this study suggest at the minimum, that CSR does not negatively impact corporate financial performance in the pharmaceutical industry. This study does not support arguments against product donations and philanthropic activities. The partial support for a positive effect of CSR on corporate financial performance and no negative impact of CSR on financial performance in the pharmaceutical industry, could encourage corporate leaders to pay attention to, not only their corporate financial profits, but also ethical, environmental, and social issues such as improving the access to medicines; and contributing to improving society.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Pharmaceutical sciences. $3 1180569
650 4 $a Public health. $3 560998
650 4 $a Finance. $3 559073
655 7 $a Electronic books. $2 local $3 554714
690 $a 0572
690 $a 0573
690 $a 0508
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Pepperdine University. $b Education. $3 1179288
773 0 $t Dissertation Abstracts International $g 79-04B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10689996 $z click for full text (PQDT)